NCT06553209View on ClinicalTrials.gov

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

August 26, 2025

Study Completion Date

September 12, 2025

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

CM512

CM512 injection

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

West China Hospital of Sichuan University, Chengdu

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06553209 - Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter